Shannon Campbell

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shannon Campbell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Director Common Stock 8,865 $22,163 $2.50 13 Dec 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30,550 12 Jun 2025 Direct

Insider Reports Filed by Shannon Campbell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 18:24
BDTX Black Diamond Therapeutics, Inc. 13 Dec 2024 1 +$11,250 4 Director 16 Dec 2024, 16:34
BDTX Black Diamond Therapeutics, Inc. 20 Sep 2024 1 +$11,252 4 Director 20 Sep 2024, 16:24
BDTX Black Diamond Therapeutics, Inc. 21 Jun 2024 1 +$10,015 4 Director 21 Jun 2024, 16:20
BDTX Black Diamond Therapeutics, Inc. 06 Jun 2024 1 $0 4 Director 06 Jun 2024, 17:52
BDTX Black Diamond Therapeutics, Inc. 10 Apr 2024 1 $0 4 Director 12 Apr 2024, 17:29
BDTX Black Diamond Therapeutics, Inc. 10 Apr 2024 0 $0 3 Director 12 Apr 2024, 17:27